Advertisement
Screener

Aurinia Pharmaceuticals Inc. (AUPH) ROA

Aurinia Pharmaceuticals Inc. (AUPH) ROA

  • 2026-06-30: ROA 39.65%.
  • 2026-03-31: ROA 41.19%.
  • 2025-12-31: ROA 38.21%.
  • 2025-09-30: ROA 14.76%.

Complete source-backed roa history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-3039.65%
2026-03-3141.19%
2025-12-3138.21%
2025-09-3014.76%
2025-06-3012.07%
2025-03-317.89%
2024-12-311.04%
2024-09-30-4.11%
2024-06-30-9.62%
2024-03-31-12.11%
2023-12-31-14.24%
2023-09-30-13.91%
2023-06-30-13.25%
2023-03-31-21.42%
2022-12-31-22.97%
2022-09-30-23.64%
2022-06-30-32.50%
2022-03-31-33.19%
2021-12-31-33.30%
2021-09-30-43.25%
2021-06-30-38.21%
2021-03-31-30.48%
2020-12-31-22.15%

Annual ROA

DateROA
2025-12-3138.21%
2024-12-311.04%
2023-12-31-14.24%
2022-12-31-22.97%
2021-12-31-33.30%
2020-12-31-22.15%
2019-12-31-27.25%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Zai Lab Ltd (ZLAB)$2.241B-113.34
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Generate Biomedicines, Inc. (GENB)United States$2.052B